Guaifenesin
/ Guaifenesin, Flowtuss, Guaifenesin, Guaifenesin /, Hycofenix, Mucinex, Obredon, Xtrelus (guaifenesin) is a small molecule pharmaceutical. Guaifenesin was first approved as Mucinex on 2002-07-12. It is used to treat allergic rhinitis perennial, bronchitis, common cold, cough, and laryngitis amongst others in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Trade Name
FDA
EMA
Guaifenesin, Mucinex
CombinationsGuaifenesin dextromethorphan, Guaifenesin pseudoephedrine, Mucinex, Mucinex d (discontinued: Flowtuss, Guaifenesin pseudoephedrine, Hycofenix, Obredon, Xtrelus)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Guaifenesin
+
Hydrocodone bitartrate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| FLOWTUSS | Chartwell Pharmaceuticals | N-022424 DISCN | 2015-05-14 | 1 products |
| XTRELUS | ECI Pharmaceuticals | N-208085 DISCN | 2018-04-25 | 1 products, RLD |
| OBREDON | Sovereign Pharmaceuticals | N-205474 DISCN | 2014-11-14 | 1 products, RLD |
Hide discontinued
Guaifenesin
+
Hydrocodone bitartrate
+
Pseudoephedrine hydrochloride
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| HYCOFENIX | Chartwell Pharmaceuticals | N-022279 DISCN | 2015-05-14 | 1 products, RLD |
Hide discontinued
Dextromethorphan hydrobromide
+
Guaifenesin
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| 12 hour mucus relief | ANDA | 2024-10-11 |
| 24/7 life cold and flu daytime severe | C200263 | 2024-12-30 |
| 7 select | C200263 | 2024-07-29 |
| acetaflu cough and chest congestion | OTC monograph final | 2020-08-31 |
| acetaminophen 500mg, dextromethorphan hbr 10mg, guaifenesin 200mg, phenylephrine hcl 5mg | OTC monograph final | 2020-11-16 |
| acetaminophen dextromethorphan hbr guaifenesin phenylephrine hcl | OTC monograph final | 2020-11-09 |
| acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride | C200263 | 2024-12-02 |
| acetaminophen, guaifenesin, dextromethorphan hbr, phenylephrine hcl | C200263 | 2024-05-17 |
| acetaminophen, guaifenesin, phenylephrine hcl and dextromethorphan hbr | C200263 | 2024-10-29 |
| actidom dmx | C200263 | 2024-06-28 |
Show 1067 more
Indications
FDA
EMA
Show 1 more
Agency Specific
FDA
EMA
No data
HCPCS
No data
Clinical
Clinical Trials
731 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pain | D010146 | EFO_0003843 | R52 | 17 | 20 | 17 | 13 | 14 | 77 |
| Postoperative pain | D010149 | — | G89.18 | 5 | 6 | 12 | 33 | 12 | 67 |
| Healthy volunteers/patients | — | — | — | 50 | 1 | — | 2 | 6 | 59 |
| Opioid-related disorders | D009293 | EFO_0005611 | F11 | 10 | 12 | 13 | 9 | 17 | 58 |
| Infections | D007239 | EFO_0000544 | — | 3 | 6 | 9 | 13 | 9 | 38 |
| Chronic pain | D059350 | — | — | 3 | 3 | 8 | 8 | 5 | 26 |
| Cough | D003371 | — | R05 | 5 | 3 | 8 | 5 | 4 | 25 |
| Syndrome | D013577 | — | — | — | 6 | 6 | 3 | 8 | 23 |
| Neoplasms | D009369 | — | C80 | 8 | 4 | 4 | 2 | 4 | 21 |
| Acute pain | D059787 | — | R52 | 5 | 4 | 6 | 1 | 3 | 19 |
Show 156 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cocaine-related disorders | D019970 | — | F14 | 4 | 3 | 2 | — | — | 8 |
| Lymphoma | D008223 | — | C85.9 | 2 | 2 | 2 | — | 1 | 6 |
| Treatment-resistant depressive disorder | D061218 | — | — | 1 | 3 | 1 | — | — | 5 |
| Psychomotor agitation | D011595 | — | — | — | 2 | 2 | — | 1 | 5 |
| Multiple myeloma | D009101 | — | C90.0 | 1 | 1 | 2 | — | 1 | 5 |
| Amyotrophic lateral sclerosis | D000690 | EFO_0000253 | G12.21 | 1 | 3 | 1 | — | — | 4 |
| Sclerosis | D012598 | — | — | — | 3 | 1 | — | — | 4 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 2 | 1 | 1 | — | — | 4 |
| Peripheral nervous system diseases | D010523 | — | G64 | — | 4 | 1 | — | — | 4 |
| Rett syndrome | D015518 | Orphanet_778 | F84.2 | — | 2 | 1 | — | 1 | 4 |
Show 58 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hyperalgesia | D006930 | — | — | 1 | 2 | — | — | 2 | 5 |
| Diarrhea | D003967 | — | R19.7 | — | 1 | — | — | 3 | 4 |
| Motor neuron disease | D016472 | EFO_0003782 | G12.2 | 1 | 3 | — | — | — | 3 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 1 | — | — | 2 | 3 |
| Fibromyalgia | D005356 | EFO_0005687 | M79.1 | 2 | 1 | — | — | — | 3 |
| Prostatic neoplasms | D011471 | — | C61 | 3 | 1 | — | — | — | 3 |
| Spinal cord injuries | D013119 | EFO_1001919 | — | — | 2 | — | — | 1 | 3 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | — | 2 | — | — | 1 | 3 |
| Irritable bowel syndrome | D043183 | EFO_0000555 | K58 | — | 1 | — | — | 2 | 3 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 2 | 2 | — | — | — | 3 |
Show 102 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Drug interactions | D004347 | — | — | 6 | — | — | — | 3 | 9 |
| Tuberculosis | D014376 | EFO_0000774 | A15-A19 | 1 | — | — | — | 1 | 2 |
| Food-drug interactions | D018565 | — | — | 2 | — | — | — | — | 2 |
| Squamous cell carcinoma of head and neck | D000077195 | — | — | 1 | — | — | — | 1 | 2 |
| Renal insufficiency | D051437 | — | N19 | 2 | — | — | — | — | 2 |
| Liver diseases | D008107 | EFO_0001421 | K70-K77 | 2 | — | — | — | — | 2 |
| Hepatic insufficiency | D048550 | — | — | 2 | — | — | — | — | 2 |
| Melanoma | D008545 | — | — | 1 | — | — | — | — | 1 |
| Hepacivirus | D016174 | — | — | 1 | — | — | — | — | 1 |
| Mitochondrial diseases | D028361 | EFO_0000591 | — | 1 | — | — | — | — | 1 |
Show 30 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Apnea | D001049 | — | R06.81 | — | — | — | — | 2 | 2 |
| Pneumonia | D011014 | EFO_0003106 | J18 | — | — | — | — | 2 | 2 |
| Emergence delirium | D000071257 | — | — | — | — | — | — | 2 | 2 |
| Whooping cough | D014917 | EFO_0000650 | A37 | — | — | — | — | 2 | 2 |
| Chronic cough | D000096822 | — | R05.3 | — | — | — | — | 2 | 2 |
| Periodontitis | D010518 | EFO_0000649 | K05.3 | — | — | — | — | 2 | 2 |
| Pregnancy rate | D018873 | — | — | — | — | — | — | 2 | 2 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 2 | 2 |
| Torsades de pointes | D016171 | EFO_0005307 | I47.21 | — | — | — | — | 1 | 1 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | — | — | 1 | 1 |
Show 59 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Guaifenesin |
| INN | guaifenesin |
| Description | Guaifenesin is a member of methoxybenzenes. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | COc1ccccc1OCC(O)CO |
Identifiers
| PDB | — |
| CAS-ID | 93-14-1 |
| RxCUI | — |
| ChEMBL ID | CHEMBL980 |
| ChEBI ID | — |
| PubChem CID | 3516 |
| DrugBank | DB00874 |
| UNII ID | 495W7451VQ (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Guaifenesin
+
Carbetapentane
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Guaifenesin
+
Carbetapentane
+
Phenylephrine
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Guaifenesin
+
Chlophedianol
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Guaifenesin
+
Phenylephrine
+
Chlorpheniramine
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Guaifenesin
+
Codeine
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Guaifenesin
+
Codeine
+
Phenylpropanolamine
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Guaifenesin
+
Dextromethorphan
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Guaifenesin
+
Dextromethorphan
+
Phenylephrine
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Guaifenesin
+
Dyphylline
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Guaifenesin
+
Ephedrine
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Guaifenesin
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Guaifenesin
+
Hydrocodone
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Guaifenesin
+
Phenylephrine
+
Hydrocodone
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Guaifenesin
+
Oxtriphylline
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Guaifenesin
+
Phenylephrine
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Guaifenesin
+
Phenylpropanolamine
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Guaifenesin
+
Pseudoephedrine
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Guaifenesin
+
Theophylline
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1,460 documents
View more details
Safety
Black-box Warning
Black-box warning for: Obredon
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
20,644 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use